Diversity of functional alterations of the ClC-5 exchanger in the region of the proton glutamate in patients with Dent disease 1.
CLCN5
ClC-5
Dent disease
kidney
proteasome
proton glutamate
Journal
Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
04
02
2021
received:
25
09
2020
accepted:
14
02
2021
pubmed:
19
2
2021
medline:
1
4
2022
entrez:
18
2
2021
Statut:
ppublish
Résumé
Mutations in the CLCN5 gene encoding the 2Cl
Substances chimiques
Chloride Channels
0
Protons
0
Glutamic Acid
3KX376GY7L
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
537-550Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Abagyan, R., & Totrov, M. (1994). Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. Journal of Molecular Biology, 235, 983-1002.
Alekov, A. K. (2015). Mutations associated with Dent's disease affect gating and voltage dependence of the human anion/proton exchanger ClC-5. Frontiers in Physiology, 6, 159.
Ashida, A., Yamamoto, D., Nakakura, H., Shirasu, A., Matsumura, H., Sekine, T., Igarashi, T., & Tamai, H. (2014). Molecular effect of a novel missense mutation, L266V, on function of ClC-5 protein in a Japanese patient with Dent's disease. Clinical Nephrology, 82, 58-61.
Ashton, E. J., Legrand, A., Benoit, V., Roncelin, I., Venisse, A., Zennaro, M.-C., Jeunemaitre, X., Iancu, D., Van't Hoff, W. G., Walsh, S. B., Godefroid, N., Rotthier, A., Del Favero, J., Devuyst, O., Schaefer, F., Jenkins, L. A., Kleta, R., Dahan, K., Vargas-Poussou, R., & Bockenhauer, D. (2018). Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney International, 93, 961-967.
Bignon, Y., Alekov, A., Frachon, N., Lahuna, O., Jean-Baptiste Doh-Egueli, C., Deschênes, G., Vargas-Poussou, R., & Lourdel, S. (2018). A novel CLCN5 pathogenic mutation supports Dent disease with normal endosomal acidification. Human Mutation, 39, 1139-1149.
Bogdanović, R., Draaken, M., Toromanović, A., Dordević, M., Stajić, N., & Ludwig, M. (2010). A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatric Nephrology, 25, 2363-2368.
Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., Salmon, J. K., Shan, Y., & Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In: SC '06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing.
Chang, M.-H., Brown, M. R., Liu, Y., Gainullin, V. G., Harris, P. C., Romero, M. F., & Lieske, J. C. (2020). Cl− and H+ coupling properties and subcellular localizations of wildtype and disease-associated variants of the voltage-gated Cl−/H+ exchanger ClC-5. Journal of Biological Chemistry, 295, 1464-1473.
Chavan, T. S., Cheng, R. C., Jiang, T., Mathews, I. I., Stein, R. A., Koehl, A., Mchaourab, H. S., Tajkhorshid, E., & Maduke, M. (2020). A CLC-ec1 mutant reveals global conformational change and suggests a unifying mechanism for the CLC Cl−/H+ transport cycle. eLife, 9, e54479.
Chen, T.-Y., & Hwang, T.-C. (2008). CLC-0 and CFTR: Chloride channels evolved from transporters. Physiological Reviews, 88, 351-387.
D'Antonio, C., Molinski, S., Ahmadi, S., Huan, L. J., Wellhauser, L., & Bear, C. E. (2013). Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of ClC-5. The Biochemical Journal, 452, 391-400.
Devuyst, O., Christie, P. T., Courtoy, P. J., Beauwens, R., & Thakker, R. V. (1999). Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Human Molecular Genetics, 8, 247-257.
Dutzler, R., Campbell, E. B., Cadene, M., Chait, B. T., & MacKinnon, R. (2002). X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature, 415, 287-294.
Dutzler, R., Campbell, E. B., & MacKinnon, R. (2003). Gating the selectivity filter in ClC chloride channels. Science, 300, 108-112.
Feng, L., Campbell, E. B., Hsiung, Y., & MacKinnon, R. (2010). Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle. Science, 330, 635-641.
Gorvin, C. M., Wilmer, M. J., Piret, S. E., Harding, B., Heuvel, L. P., van den Wrong, O., Jat, P. S., Lippiat, J. D., Levtchenko, E. N., & Thakker, R. V. (2013). Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients. Proceedings of the National Academy of Sciences of the United States of America, 110, 7014-7019.
Grand, T., L'Hoste, S., Mordasini, D., Defontaine, N., Keck, M., Pennaforte, T., Genete, M., Laghmani, K., Teulon, J., & Lourdel, S. (2011). Heterogeneity in the processing of CLCN5 mutants related to Dent disease. Human Mutation, 32, 476-483.
Grand, T., Mordasini, D., L'Hoste, S., Pennaforte, T., Genete, M., Biyeyeme, M. J., Vargas-Poussou, R., Blanchard, A., Teulon, J., & Lourdel, S. (2009). Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing. Kidney International, 76, 999-1005.
Guerriero, C. J., & Brodsky, J. L. (2012). The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiological Reviews, 92, 537-576.
Gunther, W., Luchow, A., Cluzeaud, F., Vandewalle, A., & Jentsch, T. J. (1998). ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proceedings of the National Academy of Sciences of the United States of America, 95, 8075-8080.
Gunther, W., Piwon, N., & Jentsch, T. J. (2003). The ClC-5 chloride channel knock-out mouse-An animal model for Dent's disease. Pflugers Archiv: European Journal of Physiology, 445, 456-462.
Hichri, H., Rendu, J., Monnier, N., Coutton, C., Dorseuil, O., Poussou, R. V., Baujat, G., Blanchard, A., Nobili, F., Ranchin, B., Remesy, M., Salomon, R., Satre, V., & Lunardi, J. (2011). From Lowe syndrome to Dent disease: Correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Human Mutation, 32, 379-388.
Hoopes, R. R. Jr, Raja, K. M., Koich, A., Hueber, P., Reid, R., Knohl, S. J., & Scheinman, S. J. (2004). Evidence for genetic heterogeneity in Dent's disease. Kidney International, 65, 1615-1620.
Hoopes, R. R. Jr, Shrimpton, A. E., Knohl, S. J., Hueber, P., Hoppe, B., Matyus, J., Simckes, A., Tasic, V., Toenshoff, B., Suchy, S. F., Nussbaum, R. L., & Scheinman, S. J. (2005). Dent disease with mutations in OCRL1. American Journal of Human Genetics, 76, 260-267.
Hryciw, D. H., Ekberg, J., Pollock, C. A., & Poronnik, P. (2006). ClC-5: A chloride channel with multiple roles in renal tubular albumin uptake. The International Journal of Biochemistry & Cell Biology, 38, 1036-1042.
Hryciw, D. H., Kruger, W. A., Briffa, J. F., Slattery, C., Bolithon, A., Lee, A., & Poronnik, P. (2012). Sgk-1 is a positive regulator of constitutive albumin uptake in renal proximal tubule cells. Cellular Physiology and Biochemistry, 30, 1215-1226.
Hryciw, D. H., Wang, Y., Devuyst, O., Pollock, C. A., Poronnik, P., & Guggino, W. B. (2003). Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines. The Journal of Biological Chemistry, 278, 40169-40176.
Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33-38.
Jentsch, T. J., & Pusch, M. (2018). CLC chloride channels and transporters: Structure, function, physiology, and disease. Physiological Reviews, 98, 1493-1590.
Kaminski, G. A., Friesner, R. A., Tirado-Rives, J., & Jorgensen, W. L. (2001). Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. Journal of Physical Chemistry B, 105, 6474-6487.
Lee, A., Slattery, C., Nikolic-Paterson, D. J., Hryciw, D. H., Wilk, S., Wilk, E., Zhang, Y., Valova, V. A., Robinson, P. J., Kelly, D. J., & Poronnik, P. (2015). Chloride channel ClC-5 binds to aspartyl aminopeptidase to regulate renal albumin endocytosis. American Journal of Physiology, 308, F784-F792.
Lee, S., Swanson, J. M. J., & Voth, G. A. (2016). Multiscale simulations reveal key aspects of the proton transport mechanism in the ClC-ec1 antiporter. Biophysical Journal, 110, 1334-1345.
Lourdel, S., Grand, T., Burgos, J., Gonzalez, W., Sepulveda, F. V., & Teulon, J. (2012). ClC-5 mutations associated with Dent's disease: A major role of the dimer interface. Pflugers Archiv: European Journal of Physiology, 463, 247-256.
Maduke, M., Miller, C., & Mindell, J. A. (2000). A decade of CLC chloride channels: Structure, mechanism, and many unsettled questions. Annual Review of Biophysics and Biomolecular Structure, 29, 411-438.
Mansour-Hendili, L., Blanchard, A., Le Pottier, N., Roncelin, I., Lourdel, S., Treard, C., González, W., Vergara-Jaque, A., Morin, G., Colin, E., Holder-Espinasse, M., Bacchetta, J., Baudouin, V., Benoit, S., Bérard, E., Bourdat-Michel, G., Bouchireb, K., Burtey, S., Cailliez, M., … Vargas-Poussou, R. (2015). Mutation update of the CLCN5 gene responsible for Dent disease 1. Human Mutation, 36, 743-752.
Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994). Constant pressure molecular dynamics algorithms. Journal of Chemical Physics, 101, 4177-4189.
Miller, C. (2006). ClC chloride channels viewed through a transporter lens. Nature, 440, 484-489.
Novarino, G., Weinert, S., Rickheit, G., & Jentsch, T. J. (2010). Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science (New York, NY), 328, 1398-1401.
Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011). PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. Journal of Chemical Theory and Computation, 7, 525-537.
Picollo, A., & Pusch, M. (2005). Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature, 436, 420-423.
Piwon, N., Gunther, W., Schwake, M., Bosl, M. R., & Jentsch, T. J. (2000). ClC-5 Cl−-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature, 408, 369-373.
Ramos-Trujillo, E., Gonzalez-Acosta, H., Flores, C., Garcia-Nieto, V., Guillen, E., Gracia, S., Vicente, C., Espinosa, L., Maseda, M. A., Santos, F., Camacho, J. A., & Claverie-Martin, F. (2007). A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with Dent's disease. Journal of Human Genetics, 52, 255-261.
Reed, A. A. C., Loh, N. Y., Terryn, S., Lippiat, J. D., Partridge, C., Galvanovskis, J., Williams, S. E., Jouret, F., Wu, F. T. F., Courtoy, P. J., Nesbit, M. A., Rorsman, P., Devuyst, O., Ashcroft, F. M., & Thakker, R. V. (2010). CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: Relevance to pathophysiology of Dent's disease. American Journal of Physiology, 298, F365-F380.
Robertson, J. L., Kolmakova-Partensky, L., & Miller, C. (2010). Design, function and structure of a monomeric ClC transporter. Nature, 468, 844-847.
Sakamoto, H., Sado, Y., Naito, I., Kwon, T. H., Inoue, S., Endo, K., Kawasaki, M., Uchida, S., Nielsen, S., Sasaki, S., & Marumo, F. (1999). Cellular and subcellular immunolocalization of ClC-5 channel in mouse kidney: Colocalization with H+-ATPase. The American Journal of Physiology, 277, F957-F965.
Satoh, N., Yamada, H., Yamazaki, O., Suzuki, M., Nakamura, M., Suzuki, A., Ashida, A., Yamamoto, D., Kaku, Y., Sekine, T., Seki, G., & Horita, S. (2016). A pure chloride channel mutant of CLC-5 causes Dent's disease via insufficient V-ATPase activation. Pflugers Archiv: European Journal of Physiology, 468, 1183-1196.
Scheel, O., Zdebik, A. A., Lourdel, S., & Jentsch, T. J. (2005). Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature, 436, 424-427.
Sekine, T., Komoda, F., Miura, K., Takita, J., Shimadzu, M., Matsuyama, T., Ashida, A., & Igarashi, T. (2014). Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: Genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrology, Dialysis, Transplantation, 29, 376-384.
Smith, A. J., Reed, A. A., Loh, N. Y., Thakker, R. V., & Lippiat, J. D. (2009). Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure. American Journal of Physiology, 296, F390-F397.
Søndergaard, C. R., Olsson, M. H. M., Rostkowski, M., & Jensen, J. H. (2011). Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values. Journal of Chemical Theory and Computation, 7, 2284-2295.
Steinmeyer, K., Schwappach, B., Bens, M., Vandewalle, A., & Jentsch, T. J. (1995). Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. The Journal of Biological Chemistry, 270, 31172-31177.
Tang, X., Brown, M. R., Cogal, A. G., Gauvin, D., Harris, P. C., Lieske, J. C., Romero, M. F., & Chang, M.-H. (2016). Functional and transport analyses of CLCN5 genetic changes identified in Dent disease patients. Physiological Reports, 4, e12776.
Tosetto, E., Ceol, M., Mezzabotta, F., Ammenti, A., Peruzzi, L., Caruso, M., Barbano, G., Vezzoli, G., Colussi, G., Vergine, G., Giordano, M., Glorioso, N., Degortes, S., Soldati, L., Sayer, J., D'Angelo, A., & Anglani, F. (2009). Novel mutations of the CLCN5 gene including a complex allele and A 5ʹ-UTR mutation in Dent disease 1. Clinical Genetics, 76, 413-416.
Wang, Y., Cai, H., Cebotaru, L., Hryciw, D. H., Weinman, E. J., Donowitz, M., Guggino, S. E., & Guggino, W. B. (2005). ClC-5: Role in endocytosis in the proximal tubule. American Journal of Physiology, 289, F850-F862.
Wojciechowski, D., Kovalchuk, E., Yu, L., Tan, H., Fahlke, C., Stölting, G., & Alekov, A. K. (2018). Barttin regulates the subcellular localization and posttranslational modification of human Cl−/H+ antiporter ClC-5. Frontiers in Physiology, 9, 1490.
Wu, F., Roche, P., Christie, P. T., Loh, N. Y., Reed, A. A., Esnouf, R. M., & Thakker, R. V. (2003). Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney International, 63, 1426-1432.
Zifarelli, G., De Stefano, S., Zanardi, I., & Pusch, M. (2012). On the mechanism of gating charge movement of ClC-5, a human Cl−/H+ antiporter. Biophysical Journal, 102, 2060-2069.